Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06215118
Title A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
MSK Basking Ridge NOT_YET_RECRUITING Basking Ridge New Jersey 07920 United States Details
MSK Monmouth NOT_YET_RECRUITING Middletown New Jersey 07748 United States Details
MSK Commack NOT_YET_RECRUITING Commack New York 11725 United States Details
MSK Westchester NOT_YET_RECRUITING Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy NOT_YET_RECRUITING Long Island City New York 11101 United States Details
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). NOT_YET_RECRUITING New York New York 10021 United States Details
Memorial Sloan Kettering Cancer Center - Main Campus NOT_YET_RECRUITING New York New York 10065 United States Details
Dr. Everett Chalmers Regional Hospital RECRUITING Fredericton New Brunswick E3B 5N5 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field